{"id":"https://openalex.org/W2461628610","doi":"https://doi.org/10.1080/17460441.2016.1201057","title":"The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma","display_name":"The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma","publication_year":2016,"publication_date":"2016-06-22","ids":{"openalex":"https://openalex.org/W2461628610","doi":"https://doi.org/10.1080/17460441.2016.1201057","mag":"2461628610","pmid":"https://pubmed.ncbi.nlm.nih.gov/27327499","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5443413"},"language":"en","primary_location":{"id":"doi:10.1080/17460441.2016.1201057","doi":"https://doi.org/10.1080/17460441.2016.1201057","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17460441.2016.1201057","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5443413","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102717513","display_name":"Alex Kim","orcid":"https://orcid.org/0000-0002-9774-481X","observed_orcids":["https://orcid.org/0000-0002-9774-481X"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Kim","raw_affiliation_strings":[",","Department of Surgery, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":",","institution_ids":[]},{"raw_affiliation_string":"Department of Surgery, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057675169","display_name":"Mark Steven Cohen","orcid":"https://orcid.org/0000-0002-2517-0757","observed_orcids":["https://orcid.org/0000-0002-2517-0757"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark S. Cohen","raw_affiliation_strings":[",","Department of Surgery, University of Michigan, Ann Arbor, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":",","institution_ids":[]},{"raw_affiliation_string":"Department of Surgery, University of Michigan, Ann Arbor, MI, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057675169"],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":0.6827,"has_fulltext":false,"cited_by_count":178,"citation_normalized_percentile":{"value":0.57398108,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"11","issue":"9","first_page":"907","last_page":"916"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":1.0},{"id":"https://openalex.org/keywords/braf-v600-mutation","display_name":"BRAF V600 mutation","score":0.9890000224113464},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.7310000061988831},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.8320000171661377},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5870000123977661},{"id":"https://openalex.org/keywords/mapk-pathway-reactivation","display_name":"MAPK pathway reactivation","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cutaneous-squamous-cell-carcinoma","display_name":"cutaneous squamous cell carcinoma","score":0.9520000219345093},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9897375106811523},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.788287878036499},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.714684009552002},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6156591176986694},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5033335089683533},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49727633595466614},{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.4853726625442505},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.48225146532058716},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.445411741733551},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43114393949508667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.423176109790802},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4223892390727997},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4126080572605133},{"id":"https://openalex.org/C2776470698","wikidata":"https://www.wikidata.org/wiki/Q21851559","display_name":"V600E","level":4,"score":0.41252806782722473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3536075949668884},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3424392640590668},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2694915235042572},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.19609332084655762},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10812094807624817},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077484","descriptor_name":"Vemurafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/17460441.2016.1201057","doi":"https://doi.org/10.1080/17460441.2016.1201057","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17460441.2016.1201057","pdf_url":null,"source":{"id":"https://openalex.org/S142541038","display_name":"Expert Opinion on Drug Discovery","issn_l":"1746-0441","issn":["1746-0441","1746-045X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Discovery","raw_type":"journal-article"},{"id":"pmid:27327499","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27327499","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug discovery","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5443413","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5443413","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Expert Opin Drug Discov","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5443413","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5443413","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Expert Opin Drug Discov","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8770490743","display_name":"Development and Evaluation of Purine and Coumarin Based Hsp90 Inhibitors","funder_award_id":"R01CA120458","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000862605","display_name":"University of Michigan Rogel Cancer Center Support Grant 2023-2028","funder_award_id":"P30CA046592","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332682","display_name":"Medical School, University of Michigan","ror":"https://ror.org/00jmfr291"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W115493916","https://openalex.org/W975844756","https://openalex.org/W1486631729","https://openalex.org/W1508281037","https://openalex.org/W1565041471","https://openalex.org/W1815358876","https://openalex.org/W1827097565","https://openalex.org/W1846586690","https://openalex.org/W1879616740","https://openalex.org/W1965480120","https://openalex.org/W1970195561","https://openalex.org/W1970845550","https://openalex.org/W1971947883","https://openalex.org/W1974564127","https://openalex.org/W1982972087","https://openalex.org/W1996372785","https://openalex.org/W1997656209","https://openalex.org/W2004295816","https://openalex.org/W2018155127","https://openalex.org/W2023046293","https://openalex.org/W2032211985","https://openalex.org/W2034517287","https://openalex.org/W2036237603","https://openalex.org/W2040956995","https://openalex.org/W2051165598","https://openalex.org/W2062427243","https://openalex.org/W2074089133","https://openalex.org/W2075104267","https://openalex.org/W2079421845","https://openalex.org/W2087128490","https://openalex.org/W2090359261","https://openalex.org/W2093691792","https://openalex.org/W2099044540","https://openalex.org/W2106484137","https://openalex.org/W2106543129","https://openalex.org/W2108537717","https://openalex.org/W2112276477","https://openalex.org/W2118863192","https://openalex.org/W2121545342","https://openalex.org/W2124662474","https://openalex.org/W2128542677","https://openalex.org/W2137723371","https://openalex.org/W2140777372","https://openalex.org/W2149642154","https://openalex.org/W2149662085","https://openalex.org/W2154196978","https://openalex.org/W2155381255","https://openalex.org/W2155461614","https://openalex.org/W2160378889","https://openalex.org/W2163188200","https://openalex.org/W2163563579","https://openalex.org/W2163655212","https://openalex.org/W2166112957","https://openalex.org/W2166559064","https://openalex.org/W2168143310","https://openalex.org/W2175881750","https://openalex.org/W2214943066","https://openalex.org/W2231156824","https://openalex.org/W3198835821"],"related_works":["https://openalex.org/W1969161035","https://openalex.org/W1992999500","https://openalex.org/W2066231444","https://openalex.org/W2804992444","https://openalex.org/W1994631083","https://openalex.org/W2105001532","https://openalex.org/W2468709891","https://openalex.org/W2416288369","https://openalex.org/W3000672628","https://openalex.org/W4390013090"],"abstract_inverted_index":{"INTRODUCTION:":[0],"In":[1,174],"the":[2,11,14,20,31,40,44,109,183],"era":[3],"of":[4,13,33,49,111,187,209,216],"precision":[5],"medicine":[6],"and":[7,98,104,115,130,200],"sophisticated":[8],"modern":[9],"genetics,":[10],"discovery":[12,82],"BRAF(V600)":[15,41,63,137],"inhibitor,":[16,64],"vemurafenib,":[17,65],"quickly":[18],"became":[19],"model":[21],"for":[22,46,51,163],"targeted":[23],"therapy":[24],"in":[25,86,133,150,170,180],"melanomas.":[26],"As":[27],"early":[28],"as":[29,55],"2002,":[30],"majority":[32],"metastatic":[34,87],"melanomas":[35],"were":[36],"described":[37],"to":[38,83,121,146,221],"harbor":[39],"mutation,":[42],"setting":[43],"stage":[45],"an":[47,161],"explosion":[48],"interest":[50],"targeting":[52],"this":[53],"protein":[54,210],"a":[56,70,176,205],"novel":[57],"therapeutic":[58,168],"strategy.":[59],"The":[60],"highly":[61],"selective":[62],"was":[66,140],"identified":[67],"initially":[68],"through":[69,143],"large-scale":[71],"drug":[72,184,198],"screen.":[73],"AREAS":[74],"COVERED:":[75],"Here":[76],"we":[77],"examine":[78],"vemurafenib's":[79],"journey":[80],"from":[81,204],"clinical":[84,100,144],"use":[85],"melanoma.":[88],"Topics":[89],"covered":[90],"include":[91,185],"preclinical":[92],"data,":[93],"single":[94],"agent":[95],"Phase":[96],"1,2":[97],"3":[99],"trials,":[101],"resistance":[102,169,199],"issues":[103],"mechanisms,":[105],"adverse":[106],"effects":[107],"including":[108],"development":[110,186,202],"squamous":[112,190],"cell":[113,191],"cancers,":[114],"combination":[116,227],"trials.":[117],"EXPERT":[118],"OPINION:":[119],"Due":[120],"its":[122,153],"tolerance,":[123],"low":[124],"toxicity":[125,178],"profile,":[126],"rapid":[127],"tumor":[128],"response,":[129],"improved":[131],"outcomes":[132],"melanoma":[134],"patients":[135,165,181],"with":[136],"mutations,":[138],"vemurafenib":[139],"advanced":[141],"rapidly":[142],"trials":[145],"receive":[147],"FDA":[148],"approval":[149],"2011.":[151],"While":[152],"efficacy":[154],"is":[155,195],"well":[156],"documented,":[157],"durability":[158],"has":[159,219],"become":[160],"issue":[162],"most":[164],"who":[166],"experience":[167],"approximately":[171],"6-8":[172],"months.":[173],"addition,":[175],"concerning":[177],"observed":[179],"taking":[182],"localized":[188],"cutaneous":[189],"carcinomas":[192],"(SCCs).":[193],"It":[194],"hypothesized":[196],"that":[197],"SCC":[201],"result":[203],"similar":[206],"paradoxical":[207],"activation":[208],"signaling":[211],"pathways,":[212],"specifically":[213],"MAPK.":[214],"Identification":[215],"these":[217],"mechanisms":[218],"led":[220],"additional":[222],"treatment":[223],"strategies":[224],"involving":[225],"new":[226],"therapies.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":32},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":28},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}